Judith Schwartzbaum

Prof. Judith Schwartzbaum


Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2014 in Neuro-Oncology
Verified
Journal Article
Open access
PDF file
QOQuinn T. Ostrom
Quinn T. Ostrom
LBLuc Bauchet
Luc Bauchet
FDFaith G. Davis
Faith G. Davis
IDIsabelle Deltour
Isabelle Deltour
JFJames L. Fisher
James L. Fisher
JIll S Barnholt-SloanJIll S Barnholt-Sloan
JIll S Barnholt-Sloan
Gliomas are the most common primary intracranial tumor, representing 81% of malignant brain tumors. Although relatively rare, they cause significant mortality and morbidity. Glioblastoma, the most common glioma histology (∼45% of all gliomas), has a 5-year relative survival of ∼5%. A small portion of these tumors are caused by Mendelian disorders, including neurofibromatosis, tuberous sclerosis, and Li-Fraumeni syndrome. Genomic analyses of glioma have also produced new evidence about risk and prognosis. Recently discovered biomarkers that indicate improved survival include O6-methylguanine-DNA methyltransferase methylation, isocitrate dehydrogenase mutation, and a glioma cytosine–phosphate–guanine island methylator phenotype. Genome-wide association studies have identified heritable risk alleles within 7 genes that are associated with increased risk of glioma. Many risk factors have been examined as potential contributors to glioma risk. Most significantly, these include an increase in risk by exposure to ionizing radiation and a decrease in risk by history of allergies or atopic disease(s). The potential influence of occupational exposures and cellular phones has also been examined, with inconclusive results. We provide a “state of the science” review of current research into causes and risk factors for gliomas in adults.

1 September 2006 in Nature Clinical Practice Neurology
Verified
Journal Article
Closed access
PDF file
JSJudith Schwartzbaum
Judith Schwartzbaum
JFJames L Fisher
James L Fisher
KAKenneth D Aldape
Kenneth D Aldape
MWMargaret Wrensch
Margaret Wrensch

17 September 2008 in Cancer
Verified
Journal Article
Open access
PDF file
MBMelissa L. Bondy
Melissa L. Bondy
MSMichael Scheurer
Michael Scheurer
BMBeatrice Malmer
Beatrice Malmer
JIll S Barnholt-SloanJIll S Barnholt-Sloan
JIll S Barnholt-Sloan
FDFaith G. Davis
Faith G. Davis
OCOn behalf of the Brain Tumor Epidemiology Consortium
On behalf of the Brain Tumor Epidemiology Consortium
Epidemiologists in the Brain Tumor Epidemiology Consortium (BTEC) have prioritized areas for further research. Although many risk factors have been examined over the past several decades, there are few consistent findings, possibly because of small sample sizes in individual studies and differences between studies in patients, tumor types, and methods of classification. Individual studies generally have lacked samples of sufficient size to examine interactions. A major priority based on available evidence and technologies includes expanding research in genetics and molecular epidemiology of brain tumors. BTEC has taken an active role in promoting understudied groups, such as pediatric brain tumors; the etiology of rare glioma subtypes, such as oligodendroglioma; and meningioma, which, although it is not uncommon, has only recently been registered systematically in the United States. There also is a pressing need for more researchers, especially junior investigators, to study brain tumor epidemiology. However, relatively poor funding for brain tumor research has made it difficult to encourage careers in this area. In this report, BTEC epidemiologists reviewed the group's consensus on the current state of scientific findings, and they present a consensus on research priorities to identify which important areas the science should move to address. Cancer 2008;113(7 suppl):1953–68. © 2008 American Cancer Society.

1 November 2007 in Neurologic Clinics
Verified
Journal Article
Closed access
JFJames L. Fisher
James L. Fisher
JSJudith Schwartzbaum
Judith Schwartzbaum
MWMargaret Wrensch
Margaret Wrensch
JWJoseph L. Wiemels
Joseph L. Wiemels

8 May 2000 in Archives of internal medicine (1960)
Verified
Journal Article
Open access
PDF file
AFAmy K. Ferketich
Amy K. Ferketich
JSJudith Schwartzbaum
Judith Schwartzbaum
DFDavid J. Frid
David J. Frid
MMMelvin L. Moeschberger
Melvin L. Moeschberger
DEPRESSION IS not unusual among individuals with coronary heart disease (CHD), with studies indicating that between 15% and 22% of patients suffer from depression after a cardiac event.1 In patients who have CHD, depression is associated with a reduction in both short- and long-term survival. Barefoot and coauthors2 evaluated patients with CHD for up to 19.4 years and found that depressed individuals experienced a greater risk of mortality than did nondepressed individuals. The authors speculate that long-term risk may be caused by factors that advance atherosclerosis, such as altered neuroendocrine function and failure to adhere to lifestyle behaviors that are recommended for the patient with CHD.

1 December 2014 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Closed access
PDF file
KJKimberly J. Johnson
Kimberly J. Johnson
JCJennifer Cullen
Jennifer Cullen
JIll S Barnholt-SloanJIll S Barnholt-Sloan
JIll S Barnholt-Sloan
QOQuinn T. Ostrom
Quinn T. Ostrom
CLChelsea E. Langer
Chelsea E. Langer
MSMichael Scheurer
Michael Scheurer
Childhood brain tumors are the most common pediatric solid tumor and include several histologic subtypes. Although progress has been made in improving survival rates for some subtypes, understanding of risk factors for childhood brain tumors remains limited to a few genetic syndromes and ionizing radiation to the head and neck. In this report, we review descriptive and analytical epidemiology childhood brain tumor studies from the past decade and highlight priority areas for future epidemiology investigations and methodological work that is needed to advance our understanding of childhood brain tumor causes. Specifically, we summarize the results of a review of studies published since 2004 that have analyzed incidence and survival in different international regions and that have examined potential genetic, immune system, developmental and birth characteristics, and environmental risk factors. Cancer Epidemiol Biomarkers Prev; 23(12); 2716–36. ©2014 AACR.